FBIO
Price
$2.52
Change
-$0.05 (-1.95%)
Updated
Sep 11 closing price
Capitalization
84.38M
65 days until earnings call
Intraday BUY SELL Signals
QSI
Price
$0.74
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
164.05M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FBIO vs QSI

FBIO vs QSI Comparison Chart in %
View a ticker or compare two or three
VS
FBIO vs. QSI commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIO is a StrongBuy and QSI is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QSI($164M) has a higher market cap than FBIO($84.4M). FBIO (-31.148) and QSI (-32.727) have similar YTD gains . FBIO has higher annual earnings (EBITDA): 158M vs. QSI (-90.37M). FBIO has more cash in the bank: 197M vs. QSI (112M). QSI has less debt than FBIO: QSI (3.25M) vs FBIO (53.3M). FBIO has higher revenues than QSI: FBIO (68.5M) vs QSI (1.61M).
FBIOQSIFBIO / QSI
Capitalization84.4M164M51%
EBITDA158M-90.37M-175%
Gain YTD-31.148-32.72795%
P/E Ratio0.91N/A-
Revenue68.5M1.61M4,268%
Total Cash197M112M176%
Total Debt53.3M3.25M1,638%
FUNDAMENTALS RATINGS
FBIO vs QSI: Fundamental Ratings
FBIO
QSI
OUTLOOK RATING
1..100
585
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1498
PRICE GROWTH RATING
1..100
7178
P/E GROWTH RATING
1..100
2384
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (22) in the Biotechnology industry is in the same range as QSI (45) in the null industry. This means that FBIO’s stock grew similarly to QSI’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QSI (100) in the null industry. This means that FBIO’s stock grew similarly to QSI’s over the last 12 months.

FBIO's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for QSI (98) in the null industry. This means that FBIO’s stock grew significantly faster than QSI’s over the last 12 months.

FBIO's Price Growth Rating (71) in the Biotechnology industry is in the same range as QSI (78) in the null industry. This means that FBIO’s stock grew similarly to QSI’s over the last 12 months.

FBIO's P/E Growth Rating (23) in the Biotechnology industry is somewhat better than the same rating for QSI (84) in the null industry. This means that FBIO’s stock grew somewhat faster than QSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOQSI
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (FBIO: $2.52 vs. QSI: $0.74)
Brand notoriety: FBIO and QSI are both not notable
FBIO represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FBIO: 42% vs. QSI: 42%
Market capitalization -- FBIO: $84.38M vs. QSI: $164.05M
FBIO [@Biotechnology] is valued at $84.38M. QSI’s [@Medical/Nursing Services] market capitalization is $164.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Biotechnology] industry is $2.24B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIO’s FA Score shows that 3 FA rating(s) are green while QSI’s FA Score has 0 green FA rating(s).

  • FBIO’s FA Score: 3 green, 2 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIO is a better buy in the long-term than QSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIO’s TA Score shows that 4 TA indicator(s) are bullish while QSI’s TA Score has 3 bullish TA indicator(s).

  • FBIO’s TA Score: 4 bullish, 5 bearish.
  • QSI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both FBIO and QSI are a bad buy in the short-term.

Price Growth

FBIO (@Biotechnology) experienced а -7.35% price change this week, while QSI (@Medical/Nursing Services) price change was -3.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

FBIO is expected to report earnings on Nov 16, 2026.

QSI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
FBIO
Daily Signal:
Gain/Loss:
QSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSGX17.02N/A
N/A
Morgan Stanley Inst Inception I
GMLPX45.65N/A
N/A
Goldman Sachs MLP Energy Infras Instl
FZAIX63.81N/A
N/A
Fidelity Advisor International Discv Z
VEUVX44.73N/A
N/A
JPMorgan Europe Dynamic R6
MDOEX11.98N/A
N/A
Morgan Stanley Developing Opportunity I

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-1.95%
AXON - FBIO
38%
Loosely correlated
+0.10%
FBIOP - FBIO
36%
Loosely correlated
-0.97%
QSI - FBIO
32%
Poorly correlated
+0.12%
EDIT - FBIO
31%
Poorly correlated
+1.89%
ARRY - FBIO
30%
Poorly correlated
+1.54%
More